CN100413425C - Diet fiber composition with blood lipid-reducing blood sugar-decreasing functions and its production method - Google Patents
Diet fiber composition with blood lipid-reducing blood sugar-decreasing functions and its production method Download PDFInfo
- Publication number
- CN100413425C CN100413425C CNB200510011133XA CN200510011133A CN100413425C CN 100413425 C CN100413425 C CN 100413425C CN B200510011133X A CNB200510011133X A CN B200510011133XA CN 200510011133 A CN200510011133 A CN 200510011133A CN 100413425 C CN100413425 C CN 100413425C
- Authority
- CN
- China
- Prior art keywords
- composition
- present
- blood sugar
- powder
- green tea
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 69
- 239000008280 blood Substances 0.000 title claims abstract description 51
- 210000004369 blood Anatomy 0.000 title claims abstract description 51
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 13
- 235000005911 diet Nutrition 0.000 title claims description 9
- 230000037213 diet Effects 0.000 title claims description 7
- 239000000835 fiber Substances 0.000 title claims description 7
- 229920002752 Konjac Polymers 0.000 claims abstract description 37
- 239000000843 powder Substances 0.000 claims abstract description 37
- 244000269722 Thea sinensis Species 0.000 claims abstract description 23
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 claims abstract description 22
- 229920002581 Glucomannan Polymers 0.000 claims abstract description 22
- 229940046240 glucomannan Drugs 0.000 claims abstract description 22
- 235000009569 green tea Nutrition 0.000 claims abstract description 19
- 239000002775 capsule Substances 0.000 claims abstract description 15
- 235000010489 acacia gum Nutrition 0.000 claims abstract description 14
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims abstract description 14
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims abstract description 10
- 239000007910 chewable tablet Substances 0.000 claims abstract description 10
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims abstract description 10
- 239000008108 microcrystalline cellulose Substances 0.000 claims abstract description 10
- 229940016286 microcrystalline cellulose Drugs 0.000 claims abstract description 10
- 239000000470 constituent Substances 0.000 claims abstract description 4
- 241000512259 Ascophyllum nodosum Species 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 9
- 239000003826 tablet Substances 0.000 claims description 7
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 238000005469 granulation Methods 0.000 claims description 2
- 230000003179 granulation Effects 0.000 claims description 2
- 238000012856 packing Methods 0.000 claims 1
- 235000013325 dietary fiber Nutrition 0.000 abstract description 13
- 235000010485 konjac Nutrition 0.000 abstract description 6
- 235000013376 functional food Nutrition 0.000 abstract description 5
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract description 5
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 235000013373 food additive Nutrition 0.000 abstract description 3
- 239000002778 food additive Substances 0.000 abstract description 3
- 235000021590 normal diet Nutrition 0.000 abstract description 3
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 2
- 150000002632 lipids Chemical class 0.000 abstract 2
- 241001466453 Laminaria Species 0.000 abstract 1
- 238000009098 adjuvant therapy Methods 0.000 abstract 1
- 239000005445 natural material Substances 0.000 abstract 1
- 231100000957 no side effect Toxicity 0.000 abstract 1
- 235000013305 food Nutrition 0.000 description 24
- 230000000694 effects Effects 0.000 description 9
- 230000036541 health Effects 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 8
- 239000003814 drug Substances 0.000 description 7
- 235000016709 nutrition Nutrition 0.000 description 7
- 238000010521 absorption reaction Methods 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 230000035764 nutrition Effects 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 235000013616 tea Nutrition 0.000 description 5
- 241001474374 Blennius Species 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 235000013402 health food Nutrition 0.000 description 4
- 230000000153 supplemental effect Effects 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 239000007884 disintegrant Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 2
- 241000206575 Chondrus crispus Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000003613 bile acid Substances 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 230000023852 carbohydrate metabolic process Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 150000004676 glycans Polymers 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000037356 lipid metabolism Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000003672 processing method Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- DBTMGCOVALSLOR-DEVYUCJPSA-N (2s,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](CO)O[C@H](O)[C@@H]2O)O)O[C@H](CO)[C@H]1O DBTMGCOVALSLOR-DEVYUCJPSA-N 0.000 description 1
- DIIIISSCIXVANO-UHFFFAOYSA-N 1,2-Dimethylhydrazine Chemical compound CNNC DIIIISSCIXVANO-UHFFFAOYSA-N 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000010149 Brassica rapa subsp chinensis Nutrition 0.000 description 1
- 235000000536 Brassica rapa subsp pekinensis Nutrition 0.000 description 1
- 241000499436 Brassica rapa subsp. pekinensis Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 244000205754 Colocasia esculenta Species 0.000 description 1
- 235000006481 Colocasia esculenta Nutrition 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 239000001828 Gelatine Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 229920001543 Laminarin Polymers 0.000 description 1
- 239000005717 Laminarin Substances 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010045254 Type II hyperlipidaemia Diseases 0.000 description 1
- 230000002058 anti-hyperglycaemic effect Effects 0.000 description 1
- 230000003579 anti-obesity Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000009133 cooperative interaction Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 208000026758 coronary atherosclerosis Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 238000005213 imbibition Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000004957 immunoregulator effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 229940025902 konjac mannan Drugs 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 235000020569 organic green tea Nutrition 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Polymers 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention relates to a functional food which contains konjak and has the functions of reducing blood lipid and blood sugar, more specifically to a dietary fiber composition containing konjak glucomannan and a production method thereof. The composition can be prepared to be in various portable and edible forms, such as capsules or chewable tablets, and the composition of the present invention contains 30 to 90 wt% of konjak glucomannan, 5 to 60 wt% arabic gum, 5 to 10 wt% of laminaria powder, 1 to 10 wt% of green tea powder and conventional food additive such as 0 to 20 wt% of microcrystalline cellulose. The composition of the present invention is capable of controlling the blood lipid and the blood sugar and preventing cardiovascular diseases and has the function of adjuvant treatment to Type II diabetes under the condition of not influencing the normal diet. All the constituents in the composition are natural substances beneficial to human bodies, and therefore, the dietary fiber composition has no side effect.
Description
Technical field
The present invention relates to field of food, particularly relate to and have functional food blood lipid-reducing blood sugar-decreasing functions, that contain konjaku.The present invention relates to contain the diet fiber composition of konjaku glucomannan and their production method specifically, described composition can be made and variously be suitable for storing, transport and be easy to carry and edible form, for example makes the form of capsule or chewable tablets.More specifically, the present invention utilizes the water-soluble dietary fiber characteristic of konjaku glucomannan and other plant origins, forms and produces capsule or the chewable tablets with blood lipid-reducing blood sugar-decreasing functions.
Background technology
In October, 2002, the World Health Organization once delivered report, had disclosed updated research research result: 1,000,000,000 body weight for humans exceed standard in the world at present, have emphasized fat threat to human health; Be that calendar year 2001 and fat related angiocardiopathy, diabetes and cancer become the global first cause of the death; The cancer that causes because of the diet reason accounts for 30% of cases of cancer sum in rich nations, and has also risen to 20% in this ratio of developing country.The dietary structure that the national nutrition findings of the survey of China 2002 show, three high one low (higher fatty acid, Hi CHO, high protein, low dietary fiber) causes the heat surplus, is the root that fat and relevant life style disease produces.
Relevant is that type ii diabetes and hyperlipidemia have become common disease, particularly Zhong Laonianren common disease therewith.These diseases and hyperalimentation, heat is too high, and the water-soluble dietary fiber shortage is relevant efficiently in the food.Therefore blood lipid-reducing blood sugar-decreasing becomes the important indicator of health care.Various blood lipid-reducing blood sugar-decreasing medicines and health food have appearred on the market.But there are considerable blood lipid-reducing blood sugar-decreasing medicine and health food to add chemicals in the market, the effect of these medicines normally 1) destroys the function of human body to fat absorption, its unfavorable aspect is that fat also is the part of human nutrition, as some fat soluble vitamins, must participate in just being absorbed by fat; 2) quicken fatty conversion metabolism, and the metabolite of fat is a ketone acid, the internal organ, particularly kidney of excessive ketone acid meeting major injury human body.Therefore, these medicines or food are often with in various degree side effect, and is long-term edible unfavorable to health.Press on the market and only contain natural component, the antihyperglycemic and antihypelipidemic foodstuff efficient water soluble dietary fiber, that have good result with blood lipid-reducing blood sugar-decreasing can be provided.
Konjaku has another name called mill taro, Ancient Chinese Ming Amorphophalus rivieri.The konjaku medicine of China is with a long history, becomes book on the books in " Mingyi Bielu " at Chinese end approximately.The bulb of konjaku is as traditional Chinese medicine, and it is cold in nature, flavor is hot, poisonous, major function for detumescence, attack poison, cure mainly diseases such as carbuncle sore, pyogenic infections, caking etc.In China, konjaku is as medicine and the history in existing more than 2000 year of foods using, and the food of making of konjaku is defined as one of ten big health foods by the United Nations's health organization.From the nutrition angle, konjaku is the food of a kind of low heat energy, low-protein, low vitamin, high dietary-fiber, and high dietary-fiber is its effective nutritional labeling.
In recent years, Japanese, Chinese nutrition and sanitation expert scholar have made many clinical experimental studies to health care, the medical function of konjaku.Result of study shows, the main component Glucomannan of konjaku belongs to water-soluble hemicellulose, its outstanding alimentary health-care function is to bring into play the regulating action of dietary fiber to nutritional imbalance, it with greengroceries such as Chinese cabbage, celery in contained non-water-soluble fiber enter human body after original shape discharge person different, it can participate in the metabolism of human body and influence the enteron aisle bacterium changing to helping healthy direction.A large amount of papers show that konjaku has significant health care, medical functions, and it can prevent and treat constipation; Can regulate lipid-metabolism and improve glycometabolism, can improve specificity and non-specific degree of exempting from function, have degree of exempting from and regulate active; (Zheng Jianxian writes, functional food, light industry publishing house, 1995 to have antiobesity action etc.; Sun Yuanming, Huang Xiaoyu, Wu Qing etc., the structure of konjaku glucomannan, bromatology character and health care, food and fermentation industries, 1999,25 (5): 47-51; Li Guoxiong, Xu Jingyao, konjaku glucomannan brings out the influence of mice colorectal cancer to Dimethylhydrazine, China's digestion magazine, 2000,20 (1): 59-60; Cao Hongguang, Liu Junhong, the present Research and the prospect of compound sugar and symbiotic compound thereof, food development 2004 (1): 73; Huang Chengyu: konjak food is to the research of diabetic's blood sugar influence, Journal of Nutrition, 1989,11 (4): 360; Sun Shenlu etc., polysaccharide structures and health care thereof, " Chinese food journal " 2003, supplementary issue: 496: Wang Hong encourages and builds honor, the exploitation present situation of konjak food and development 2004, (1): 115; Shimizu H, Yamauchi M, Kuramoto T, Kubota N, Matsuda M, Hoshita T, Effects of dietary konjac mannan on serum and livercholesterol levels, Pharmacobiodyn, 1,991 14 (7): 317-325).
Glucomannan is again a kind of natural plant gum, but compare with other natural gum such as xanthans, guar gum, locust bean gum etc., its viscosity is higher, be reduced to below 3.8 in the pH value, still keep stablizing and not precipitating, and splendid synergy is arranged after composite with other glue such as xanthans, carragheen etc., the viscosity of these glue is increased greatly, the invertibity gel appears, and reach maximum gel strength (He Dongbao, the research of carragheen and konjaku glucomannan cooperative interaction and gelatine thereof, polymer material science and engineering, 2001,17 (2): 28-30).
Because the premium properties that konjaku had, disclose some in recent years and contained the health food konjaku composition, that have blood lipid-reducing blood sugar-decreasing functions, Chinese patent application numbers 98125046.7,98101000.8 or the like for example, they all are with the composition of konjaku flour as food, and effect is also not ideal enough.
The present invention uses the above-mentioned excellent function of konjaku glucomannan, can regulate lipid-metabolism and improve glycometabolism, can improve specificity and non-specific degree of exempting from function, has immunoregulatory activity, is made into the functional food with blood lipid-reducing blood sugar-decreasing.Thereby provide a kind of food compositions safe and reliable, that have blood lipid-reducing blood sugar-decreasing functions, said composition contains active component Glucomannan and Arabic gum, kelp powder and the green tea powder of konjaku, can be under the situation that does not influence normal diet, control blood sugar and blood fat, angiocardiopathy preventing has the supplemental treatment effect to type ii diabetes.All the components all is the natural materials to the human body beneficial in the said composition, therefore can not produce any side effect.
Summary of the invention
The object of the present invention is to provide a kind of Konjak dietary fiber that contains, can effectively control body weight, have the functional food composition of blood lipid-reducing blood sugar-decreasing functions.
Blood lipid-reducing blood sugar-decreasing diet fiber composition of the present invention contains konjaku glucomannan, Arabic gum, kelp powder and green tea powder, and can add field of food additive commonly used as required, for example can be used as the microcrystalline cellulose that excipient and/or disintegrant use.
The percetage by weight that each constituent content accounts for total composition in the described blood lipid-reducing blood sugar-decreasing diet fiber composition is respectively:
Konjaku glucomannan is approximately 30-89%;
Arabic gum is approximately 5-60%;
The kelp powder is approximately 5-10%;
The green tea powder is approximately 1-10%; With
Microcrystalline cellulose 0-20%.
The composition of the preferred present composition is:
Konjaku glucomannan is approximately 50-80%;
Arabic gum is approximately 10-30%;
The kelp powder is approximately 5-10%;
The green tea powder is approximately 3-8%; With
Microcrystalline cellulose 0-10%.
The percentage composition of the most preferred present composition for example is:
Konjaku glucomannan is approximately 55%;
Arabic gum is approximately 25%;
The kelp powder is approximately 10%;
The green tea powder is approximately 5%; With
Microcrystalline cellulose is approximately 5%.
Konjaku glucomannan is the water-soluble dietary fiber of HMW, can select commercially available highly purified highly finished product for use, the specification of producing as Shanghai profit wound food science and technology Development Co., Ltd is the product of PP120, molecular weight should reach about 1,000,000, it is a water-soluble dietary fiber, meets behind the water at stomach expansion rate up to 100 times is provided, and only needs just can form mucus at stomach on a small quantity, embedding and absorption starch and fat food can reduce blood sugar and blood fat.Particularly can complement each other to form the sticking shape material that freezes with Arabic gum, this is sticking to freeze the shape material and can wrap up starch material, delays blood sugar and raises, the control diabetes; Bile acid is had adsorption function, can effectively reduce low-density lipoprotein, have the hypoglycemic double action.
Arabic gum is the water-soluble dietary fiber of HMW, can select for use purity to reach highly finished product more than 95%, has very strong emulsification, fatty material can be embedded in sticking freeze taken out of in the thing external.
Contain laminarin in the kelp powder, have the function that reduces blood fat and blood sugar.Used kelp powder can be selected commercially available smart powder for use in the present composition, as the kelp powder of Jiangnan, Qingdao bright moon seaweed industry company.
The green tea powder is that processing obtains after the green tea drying, can select commercially available organic green-tea ultra micro powder for use, as the precious Food Co., Ltd of Hangzhou tender tea leaves ultrafine green tea powder.The Tea Polyphenols that is contained in the green tea has the reduction blood fat, prevents lipid peroxidation, and prevention of arterial is atherosis, the function that antithrombotic forms and improves immunity of organisms.
Another object of the present invention has provided the present composition the be more convenient for form of carrying and eating, for example form of capsule or chewable tablets tablet.
Another object of the present invention has provided the method for producing the present composition, and described method can be undertaken by the conventional production method of field of food.
Another object of the present invention has provided the further method for processing of the present composition, and described processing method can be undertaken by the conventional production method of field of food.
Production ten thousand methods of the present composition and the processing method of preparation can be carried out according to conventional method, the application conventional equipment of this area.Can add field of food additive commonly used according to those skilled in the art's general knowledge in the production, for example carrier, excipient, diluent, disintegrant, aromatic, colouring agent, sweetener etc., as can be used as the microcrystalline cellulose that excipient and/or disintegrant use.For example under the condition of control sterilization, the various compositions that will prepare burden with batch mixer or kneader mix described conventional method, can obtain the present composition.In order to be suitable for storage, transportation and instant edible, described composition process preparation can be become suitable form.The form of capsule or chewable tablets for example.For example the direct can of the present composition can be made capsule in capsule; Or, be pressed into tablet with tablet press machine with after its granulation drying.
The present composition has the effect of good reduction blood pressure and blood lipoid.Be applicable to the people at highest risk of angiocardiopathy, can under the situation that does not influence normal diet, reduce hypoglycemic, angiocardiopathy preventing.The supplemental treatment that also can be used for high fat of blood and type ii diabetes patient.
In order to reach the blood lipid-reducing blood sugar-decreasing purpose, the use amount of the present composition is the about 0.5-8 gram of per day for adults normally, and preferred amount ranges is about 1-5 gram, and most preferred consumption is about 3-4 gram.Divide every day and take for 1-2 time.Time of Administration is preferably with 10 minutes before the meal, and is the most desirable before the supper.
The invention provides a kind of safe and reliable food for reducing blood sugar and blood fat composition without any side effects, or its dosage form, for example capsule or chewable tablets, its beneficial effect is:
1, the composition of product all obtains from natural food, and is without any side effects, is fit to each age group and uses;
2, own empty calory can produce solubility thickness colloid in the stomach imbibition, embedding starch and other polysaccharide foods, slowed down time of conversion of glucose, blood sugar is mild, having reduced postprandial blood sugar, helped the reparation of islet cells, is type ii diabetes people's desirable supplemental treatment food;
3, solubility thickness colloid has reduced fatty absorption by physical absorption and embedding, and absorption of bile acid reduces low-density lipoprotein, and supplemental treatment fatty liver and gall stone help preventing coronary atherosclerosis, the prevention cardiovascular and cerebrovascular disease.
The specific embodiment
In order further to set forth related product of present technique and method, provided following embodiment.But, the scope that these embodiment do not limit the present invention in any way.
The preparation of embodiment 1 present composition
Use the following feedstock production present composition:
Konjaku glucomannan, the PP-120 of Shanghai Rechy Food Science ﹠ Technology Development Co., Ltd. 180 grams;
Arabic gum, I the HP of nurse company level 75 restrains the Sudan;
The kelp powder, Jiangnan, Qingdao bright moon seaweed industry company kelp powder 30 grams; With
The green tea powder, the precious Food Co., Ltd of Hangzhou tender tea leaves ultrafine green tea powder 15 grams.
The preparation method:
Under the condition of control sterilization, with batch mixer the above-mentioned raw materials composition is mixed, obtain present composition 300g.
The preparation of embodiment 2 present compositions
According to the method identical,, prepare composition of the present invention just according to following prescription with embodiment 1:
Konjaku glucomannan, the PP-120 of Shanghai Rechy Food Science ﹠ Technology Development Co., Ltd., 165 grams;
Arabic gum, I the HP of nurse company level 75 restrains the Sudan;
The kelp powder, Jiangnan, Qingdao bright moon seaweed industry company kelp powder 30 grams;
The green tea powder, the precious Food Co., Ltd of Hangzhou tender tea leaves ultrafine green tea powder, 15 grams; With
Microcrystalline cellulose, 15g.
Prepare the 300g present composition.
The preparation of embodiment 3 present compositions
According to the method identical,, prepare composition of the present invention just according to following prescription with embodiment 1:
Konjaku glucomannan, the PP-120 of Shanghai Rechy Food Science ﹠ Technology Development Co., Ltd. 240 grams;
Arabic gum, I the HP of nurse company level 30 restrains the Sudan;
The kelp powder, Jiangnan, Qingdao bright moon seaweed industry company kelp powder 15 grams; With
The green tea powder, the precious Food Co., Ltd of Hangzhou tender tea leaves ultrafine green tea powder, 15 grams.
Prepare the 300g present composition.
The preparation of embodiment 4 capsules of the present invention
Respectively with embodiment 1,2 or the direct can of 3 resultant composition in 100 capsules, obtain the capsule of the present composition, the weight that each capsule contains embodiment 1,2 or 3 compositions is 0.3g.
The preparation of embodiment 5 chewable tablets tablets of the present invention
With embodiment 2 resultant composition granulate dry, be pressed into 100 in the tablet of heavy 0.3g with tablet press machine, obtain chewable tablets of the present invention.
Below described embodiment of the present invention in detail, can do a lot of improvement and variation obviously for a person skilled in the art and can not deviate from essence spirit of the present invention.All these changes and improvements are all within protection scope of the present invention.
Claims (7)
1. blood lipid-reducing blood sugar-decreasing diet fiber composition, the percetage by weight that the component kind in the described composition and each components contents account for total composition is as follows:
Konjaku glucomannan 30-89%;
Arabic gum 5-60%;
Kelp powder 5-10%;
Green tea powder 1-10%;
Microcrystalline cellulose 0-20%.
2. according to the composition of claim 1, the percetage by weight that each constituent content accounts for total composition in the described composition is respectively:
Konjaku glucomannan 50-80%;
Arabic gum 10-30%;
Kelp powder 5-10%;
Green tea powder 3-8%; With
Microcrystalline cellulose 0-10%.
3. according to the composition of claim 2, the percetage by weight that each constituent content accounts for total composition in the described composition is respectively:
Konjaku glucomannan 55%,
Arabic gum 25%,
Kelp powder 10%,
Green tea powder 5% and
Microcrystalline cellulose 5%.
4. according to any one composition of claim 1-3, described composition can be made the form of capsule or chewable tablets.
5. according to any composition manufacturing method of claim 1-4, this method is under the condition of control sterilization, and the various compositions of filling a prescription are mixed, and obtains described composition.
6. according to the composition production method of claim 5, the direct can of resultant composition in capsule, is obtained capsule.
7. according to the composition production method of claim 5, the resultant composition granulation is dry, compressing tablet packing obtains chewable tablets.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB200510011133XA CN100413425C (en) | 2005-01-07 | 2005-01-07 | Diet fiber composition with blood lipid-reducing blood sugar-decreasing functions and its production method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB200510011133XA CN100413425C (en) | 2005-01-07 | 2005-01-07 | Diet fiber composition with blood lipid-reducing blood sugar-decreasing functions and its production method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1799410A CN1799410A (en) | 2006-07-12 |
| CN100413425C true CN100413425C (en) | 2008-08-27 |
Family
ID=36809793
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB200510011133XA Expired - Fee Related CN100413425C (en) | 2005-01-07 | 2005-01-07 | Diet fiber composition with blood lipid-reducing blood sugar-decreasing functions and its production method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100413425C (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101243858B (en) * | 2008-03-07 | 2011-11-02 | 深圳职业技术学院 | Method of preparing edible essence microcapsule of konjak glue |
| CN103142724B (en) * | 2013-03-29 | 2015-06-10 | 成都乾坤动物药业有限公司 | Veterinary ephedra-almond-gypsum-licorice chewable tablet and preparation process thereof |
| WO2024201329A1 (en) * | 2023-03-27 | 2024-10-03 | Vivatis Pharma Gmbh | Novel combinations comprising konjac mannan, their compositions and uses thereof |
| WO2024201327A1 (en) | 2023-03-27 | 2024-10-03 | Vivatis Pharma Gmbh | Novel combinations comprising konjac mannan, their compositions and uses thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1121781A (en) * | 1994-05-13 | 1996-05-08 | 王金萍 | Pure-natural full-nutrient weight-loss food and its preparing method |
| CN1280829A (en) * | 2000-05-23 | 2001-01-24 | 吴承亚 | Konjak-glucomannan capsule |
| CN1319343A (en) * | 2001-03-30 | 2001-10-31 | 四川省广汉市育松有限责任公司 | Health care food having functions of reducing weight and preventing cardiovascular disease |
| CN1403017A (en) * | 2002-10-24 | 2003-03-19 | 田轩 | Selenium-rich konjaku-green tea health food |
| CN1411739A (en) * | 2001-10-19 | 2003-04-23 | 安徽大学 | Konjak glucomannan degradation product and ginkgo leaf extract health-care food and its preparation method |
-
2005
- 2005-01-07 CN CNB200510011133XA patent/CN100413425C/en not_active Expired - Fee Related
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1121781A (en) * | 1994-05-13 | 1996-05-08 | 王金萍 | Pure-natural full-nutrient weight-loss food and its preparing method |
| CN1280829A (en) * | 2000-05-23 | 2001-01-24 | 吴承亚 | Konjak-glucomannan capsule |
| CN1319343A (en) * | 2001-03-30 | 2001-10-31 | 四川省广汉市育松有限责任公司 | Health care food having functions of reducing weight and preventing cardiovascular disease |
| CN1411739A (en) * | 2001-10-19 | 2003-04-23 | 安徽大学 | Konjak glucomannan degradation product and ginkgo leaf extract health-care food and its preparation method |
| CN1403017A (en) * | 2002-10-24 | 2003-03-19 | 田轩 | Selenium-rich konjaku-green tea health food |
Non-Patent Citations (4)
| Title |
|---|
| 膳食纤维与脂代谢. 吴杰.国外医学卫生学分册，第2期. 1993 |
| 膳食纤维与脂代谢. 吴杰.国外医学卫生学分册，第2期. 1993 * |
| 魔芋多糖胶囊对糖尿病模型动物降血糖作用的实验研究. 丁伟平，杨金奎.江苏预防医学，第1期. 1996 |
| 魔芋多糖胶囊对糖尿病模型动物降血糖作用的实验研究. 丁伟平，杨金奎.江苏预防医学，第1期. 1996 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1799410A (en) | 2006-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU734183B2 (en) | Compositions of plant carbohydrates as dietary supplements | |
| CN102188565B (en) | Weight-losing soft capsules and preparation method thereof | |
| CN101322778B (en) | Double-layer sustained release tablets for compensating iron and preparation thereof | |
| CN101309688A (en) | Compositions and methods for the sustained release of beta-alanine | |
| WO2005084457A1 (en) | Artificial fruit | |
| CN100367879C (en) | Diet fiber composition with fat-reducing face-beautifying functions and its production method | |
| CN100411655C (en) | Composition comprising panax ginseng and paullinia cupana extracts | |
| CN101683477A (en) | Composition for fat-reducing | |
| CN100401920C (en) | Diet fiber composition with intestine-nourishing constipation-releving functions and its production method | |
| CN108567936A (en) | Appetite-stimulating and indigestion-relieving Chinese medicine composition, preparation and preparation method thereof | |
| CN101129351A (en) | Iron supplement composition, its preparing method and application of the same | |
| CN108835638A (en) | A kind of Soboring-up liver-protecting improves the food and preparation method thereof of immunity | |
| CN1820647A (en) | Nutrition powder for increasing memory | |
| CN100413425C (en) | Diet fiber composition with blood lipid-reducing blood sugar-decreasing functions and its production method | |
| CN101912110B (en) | Composite with effects of losing weight and lowering blood sugar and blood lipid | |
| CN101664180B (en) | Health-care nutritional complexing agent with health effect and preparation method thereof | |
| CN102847159A (en) | A glucose metabolism enhancer | |
| CN105410930A (en) | Health-care product with weight-losing and body-slimming and nutrition-balancing functions and preparation method thereof | |
| CN101427778A (en) | Health care instant noodles and method of producing the same | |
| RU2283124C1 (en) | Biologically active preparation based on marine vegetable raw | |
| Bikash et al. | Formulating anti-diabetic nutraceutical tablets based on edible plants from Tripura, India | |
| CN101816427A (en) | Mixture of black fungi, royal jelly and giant salamander full powder and preparation method thereof | |
| CN105249441A (en) | Folium mori health care product for reducing blood glucose and preparation method thereof | |
| CN101524153A (en) | Health-care wheat flour beneficial for diabetes patients | |
| CN101347229A (en) | Health food with bowel relaxing function and production method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: SHANGHAI RUNCHUANG FOODS SCIENCE + TECHNOLOGY DEVE Free format text: FORMER OWNER: ZHOU MI Effective date: 20110325 Owner name: SHANGHAI RUNCHUANG BIOTECHNOLOGY CO., LTD. |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 200336 ROOM 1001, NO. 28, LANE 585, TIANSHAN ROAD, SHANGHAI TO: 201700 310-F, NO. 485, PUCANG ROAD, QINGPU DISTRICT, SHANGHAI |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20110325 Address after: 201700 Shanghai, Qingpu District, road, No. 485 Co-patentee after: Shanghai run Biological Technology Co., Ltd. Patentee after: Shanghai run Food Technology Development Co., Ltd. Address before: 1001 room 28, Lane 585, Lane 200336, Tian Shan Road, Shanghai Patentee before: Zhou Fu |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080827 Termination date: 20170107 |